Camp4 Therapeutics Corporation
CAMP
$2.05
$0.063.02%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 1.52% | -7.75% | 0.00% | 3.66% | -11.07% |
| Total Depreciation and Amortization | 0.00% | -2.79% | 0.00% | -1.15% | 1.16% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -38.09% | 63.12% | 0.00% | 16.56% | -3.64% |
| Change in Net Operating Assets | -77.36% | 189.25% | 0.00% | -371.15% | -108.70% |
| Cash from Operations | -16.46% | 21.13% | 0.00% | -4.31% | -79.78% |
| Capital Expenditure | -- | 100.00% | 0.00% | 63.37% | -17.39% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 100.00% | 0.00% | 63.37% | -17.39% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.93% | -0.49% | 0.00% | 13.56% | -15.69% |
| Issuance of Common Stock | 246,458.06% | 3,000.00% | 0.00% | -99.42% | 17,200.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1,390.57% | 30.26% | 0.00% | -- | -- |
| Cash from Financing | 19,027.98% | 23.87% | 0.00% | -704.76% | 68.97% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 710.29% | 21.79% | 0.00% | -6.60% | -73.59% |